EUVIMEDEUVIMED entdecken
Open Access

TMEM106B Fibrils from FTLD Patients and Healthy Controls

James D Greenwood, Wyatt C Powell, Maciej A Walczak iD

ACS Chemical Neuroscience · 2023

DOI: 10.1021/acschemneuro.3c00482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2023. Verfasst von James D Greenwood und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Colorado, Boulder, Colorado 80309, United States. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Frontotemporal Lobar Degeneration. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies involving four research teams have revealed that amyloid fibrils in FTLD-TDP patients and cognitively healthy individuals primarily consist of TMEM106B, a protein previously identified as a risk factor for FTLD-TDP. Through cryogenic electron microscopy, the studies identified various protofilament structures of TMEM106B fibrils from individuals with several neurodegenerative diseases. These findings raise new questions and opportunities for future research, as they suggest that TMEM106B plays a central role in FTLD pathology. These discoveries also prompt the need for the development of specific antibodies for fibrillar TMEM106B and necessitate further investigation of the potential mechanistic link between TMEM106B and other filamentous aggregates. The power of cryo-EM techniques is underscored in these unexpected findings and may be a vital tool for gaining further molecular insights into neurodegenerative diseases characterized by amyloid deposits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaFrontotemporal Lobar DegenerationHumansMembrane ProteinsGenotypeNerve Tissue ProteinsPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

FTLD pathologyFTLD-TDPTMEM106Bamyloid depositsamyloid fibrilsfilamentous aggregates

Substanzen

Membrane ProteinsNerve Tissue ProteinsTMEM106B protein, human

Autor:innen und Institutionen

  • Department of Chemistry, University of Colorado, Boulder, Colorado 80309, United States.

ORCID-Profile: Maciej A Walczak

Förderung

  • NIA NIH HHS
  • National Institute on Aging

Zitieren

APA

Greenwood, J. D., Powell, W. C., & Walczak, M. A. (2023). TMEM106B Fibrils from FTLD Patients and Healthy Controls. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.3c00482

Vancouver

Greenwood JD, Powell WC, Walczak MA. TMEM106B Fibrils from FTLD Patients and Healthy Controls. ACS Chemical Neuroscience. 2023. doi:10.1021/acschemneuro.3c00482

BibTeX
@article{Greenwood2023,
  author = {Greenwood, James D and Powell, Wyatt C and Walczak, Maciej A},
  title = {TMEM106B Fibrils from FTLD Patients and Healthy Controls},
  journal = {ACS Chemical Neuroscience},
  year = {2023},
  doi = {10.1021/acschemneuro.3c00482}
}
Kostenlos starten →